VERU INC. Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
VERU INC. (VERU) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $0 for the 9-month period ending 2022-06-30, per its 10-Q filed 2022-08-11.
Discontinued › Notes › and Others › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2022-08-11
- VERU INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2022-06-30 was $0.00.
- VERU INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2022-03-31 was $0.00.
- VERU INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2021-12-31 was $0.00.
- VERU INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2021-06-30 was $0.00.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 6 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2022-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $0.00 derived: sum of 2 quarters · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 |
| 2022-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | $0.00 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $0.00 10-Q · filed 2022-02-09 | ||
| 2021-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $0.00 derived: sum of 2 quarters · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 |
| 2021-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | $0.00 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $0.00 10-Q · filed 2022-02-09 | ||
| 2020-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | $0.00 derived: sum of 2 quarters · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 |
| 2020-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-12 | $0.00 10-Q · filed 2021-05-12 | |
| 2019-12-31 | $0.00 10-Q · filed 2021-02-10 | ||
| 2018-12-31 | $0.00 10-Q · filed 2020-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |